BIOMAT Database Logo BIOMAT Database Logo

Comparison of isoproterenol and isoproterenol-phenylephrine aerosols. 1971

J L Grant, and N Werfelman, and M R Cook, and W Metherall

UI MeSH Term Description Entries
D007545 Isoproterenol Isopropyl analog of EPINEPHRINE; beta-sympathomimetic that acts on the heart, bronchi, skeletal muscle, alimentary tract, etc. It is used mainly as bronchodilator and heart stimulant. Isoprenaline,Isopropylarterenol,4-(1-Hydroxy-2-((1-methylethyl)amino)ethyl)-1,2-benzenediol,Euspiran,Isadrin,Isadrine,Isopropyl Noradrenaline,Isopropylnoradrenaline,Isopropylnorepinephrine,Isoproterenol Hydrochloride,Isoproterenol Sulfate,Isuprel,Izadrin,Norisodrine,Novodrin,Hydrochloride, Isoproterenol,Noradrenaline, Isopropyl,Sulfate, Isoproterenol
D008171 Lung Diseases Pathological processes involving any part of the LUNG. Pulmonary Diseases,Disease, Pulmonary,Diseases, Pulmonary,Pulmonary Disease,Disease, Lung,Diseases, Lung,Lung Disease
D008173 Lung Diseases, Obstructive Any disorder marked by obstruction of conducting airways of the lung. AIRWAY OBSTRUCTION may be acute, chronic, intermittent, or persistent. Obstructive Lung Diseases,Obstructive Pulmonary Diseases,Lung Disease, Obstructive,Obstructive Lung Disease,Obstructive Pulmonary Disease,Pulmonary Disease, Obstructive,Pulmonary Diseases, Obstructive
D008297 Male Males
D008722 Methods A series of steps taken in order to conduct research. Techniques,Methodological Studies,Methodological Study,Procedures,Studies, Methodological,Study, Methodological,Method,Procedure,Technique
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010656 Phenylephrine An alpha-1 adrenergic agonist used as a mydriatic, nasal decongestant, and cardiotonic agent. (R)-3-Hydroxy-alpha-((methylamino)methyl)benzenemethanol,Metaoxedrin,Metasympatol,Mezaton,Neo-Synephrine,Neosynephrine,Phenylephrine Hydrochloride,Phenylephrine Tannate,Neo Synephrine,Tannate, Phenylephrine
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D012138 Respiratory Therapy Care of patients with deficiencies and abnormalities associated with the cardiopulmonary system. It includes the therapeutic use of medical gases and their administrative apparatus, environmental control systems, humidification, aerosols, ventilatory support, bronchopulmonary drainage and exercise, respiratory rehabilitation, assistance with cardiopulmonary resuscitation, and maintenance of natural, artificial, and mechanical airways. Inhalation Therapy,Therapy, Inhalation,Therapy, Respiratory,Inhalation Therapies,Respiratory Therapies,Therapies, Inhalation,Therapies, Respiratory
D001993 Bronchodilator Agents Agents that cause an increase in the expansion of a bronchus or bronchial tubes. Bronchial-Dilating Agents,Bronchodilator,Bronchodilator Agent,Broncholytic Agent,Bronchodilator Effect,Bronchodilator Effects,Bronchodilators,Broncholytic Agents,Broncholytic Effect,Broncholytic Effects,Agent, Bronchodilator,Agent, Broncholytic,Agents, Bronchial-Dilating,Agents, Bronchodilator,Agents, Broncholytic,Bronchial Dilating Agents,Effect, Bronchodilator,Effect, Broncholytic,Effects, Bronchodilator,Effects, Broncholytic

Related Publications

J L Grant, and N Werfelman, and M R Cook, and W Metherall
Ventilatory responses to aerosols of isoproterenol and isoproterenol-phenylephrine.
December 1962, Current therapeutic research, clinical and experimental,
J L Grant, and N Werfelman, and M R Cook, and W Metherall
COMPARISON OF THE PROTECTIVE EFFECT OF ISOPROTERENOL WITH ISOPROTERENOL-PHENYLEPHRINE AEROSOLS IN ASTHMATICS.
January 1964, International archives of allergy and applied immunology,
J L Grant, and N Werfelman, and M R Cook, and W Metherall
Effects of isoproterenol and isoproterenol-phenylephrine aerosols on hypertensive asthmatic patients.
May 1968, The Journal of allergy,
J L Grant, and N Werfelman, and M R Cook, and W Metherall
A comparison of the cardiorespiratory effects of salbutamol and isoproterenol-phenylephrine aerosols in asthma.
November 1971, The American review of respiratory disease,
J L Grant, and N Werfelman, and M R Cook, and W Metherall
Isoproterenol aerosols.
April 1975, Annals of allergy,
J L Grant, and N Werfelman, and M R Cook, and W Metherall
Comparison of the effect on blood gases, ventilation, and perfusion of isoproterenol-phenylephrine and salbutamol aerosols in chronic bronchitis with asthma.
February 1972, The Journal of allergy and clinical immunology,
J L Grant, and N Werfelman, and M R Cook, and W Metherall
Comparison of albuterol and isoproterenol aerosols in bronchial asthma.
December 1977, Annals of allergy,
J L Grant, and N Werfelman, and M R Cook, and W Metherall
Comparison of fenoterol, isoproterenol, and isoetharine with phenylephrine aerosol in asthma.
January 1983, Journal of clinical pharmacology,
J L Grant, and N Werfelman, and M R Cook, and W Metherall
Comparison of metaproterenol and isoproterenol aerosols: spirometric evaluation after two months' therapy.
December 1969, Annals of allergy,
J L Grant, and N Werfelman, and M R Cook, and W Metherall
Comparison of the bronchodilator activities of isoproterenol and of prostaglandin E 1 aerosols.
April 1973, Chest,
Copied contents to your clipboard!